Actelion forsikrer, at der føres en opsamlingsprotokol for alle patienter, der er i behandling med Zavesca i de igangværende kliniske studier vedrørende type 1 Gauchers sygdom.
Actelion will ensure that a capture protocol is continued for all patients currently receiving Zavesca in the ongoing type 1 Gaucher disease clinical studies.